Hospital Clinic, IDIBAPS, University of Barcelona
Head of the Oncoimmunotherapy Unit and consultant haematologist
John De Vos is Professor of Embryology, Histology and Regenerative Medicine at the Faculty of Medicine of Montpellier, and head of the Cellular and Tissue Engineering Department of the University Hospital Center (CHU) of Montpellier. His research, at the Research...
En savoir +Nathalie Labarriere is Inserm Research Director, in charge of the team 3 « Anti-tumor immunosurveillance and immunotherapy» and deputy director of the INCIT Unit (Immunology and new concepts in Immunotherapy). She started working in 1990 on tumor immunology in Nantes...
En savoir +Doctor in Immunology, researcher at and former director of the Autoimmunity-Transplantation-Inflammation research team at the INSERM-Univ Franche Comté-EFS Joint Research Unit 1098 RIGHT in Besançon (FR) for the last 10 years, Dr Perruche is now the founder and CEO of...
En savoir +Gavin joined MabDesign in 2019 and currently holds the position of Head of Scientific Affairs & Business Intelligence. In this role, Gavin oversees the strategic development and implementation of scientific initiatives including MabDesign’s Watchs editions, our multiple types of scientific...
En savoir +Dr Olivier Humbey (PhD) is a Business Developer at IQVIA offering international Real World Data solutions to Biotechs at each stage of their product life cycle development (from early clinical to post-marketing). He works strategically with cross department services to...
En savoir +Julien Branchu focused his scientific career on the discovery of innovative therapeutic targets that could improve the daily lives of patients. After several internships in neuroscience field, he joined Pr. F. Charbonnier's group for his PhD. Using in vitro and...
En savoir +Stéphane Maddens is the founder and CEO of Vetbiobank, a clinical-stage biotech based in Lyon (France) and specialised in developing and manufacturing cell-based drugs for animal health. He holds a pharmacy degree specialised in cell therapy applied to hemato-oncology diseases...
En savoir +Sebastian Amigorena is “Directeur de Recherche Classe Exceptionnelle” at CNRS, Director of the “Center of Immunotherapy for cancers” and the “Immune responses and cancer” Team at Institut Curie (Paris, France), in the Immunology Department "Immunity and Cancer" that he created...
En savoir +European Regulation (EC) No 1394/2007 created a new class of drugs in 2007 called : “Advanced Therapy Medicinal Products”, resulting from cellular and tissue engineering, genetic manipulation, and possibly combined with medical devices. More than fifteen years after the implementation...
En savoir +After studying biology at the University of Sciences in Besançon, Sylvie defended her thesis based on cytogenetic and molecular prenatal diagnostic tools in Pr. Bresson's cytogenetics laboratories in Besançon. Then she went to Montreal, Quebec, as a laboratory coordinator at...
En savoir +President-Elect and Board of Directors member of the International Society of Cell and Gene Therapy (ISCT) from May 2022. Previously Chief Commercialization Officer and Chair of the ISCT Commercialization Committee (2014-2020) leading the expansion of the industrial community, strengthening the...
En savoir +JCM is the Associate Director for Tissues, Cells and Advanced Therapies (TCAT) at the SNBTS and an Honorary Reader at University of Edinburgh. As an experienced experimental haematologist and stem cell biologist Jo’s focus is the assessment, development and translation...
En savoir +Since more than 20 years, I have been interested in the field of the T-cell response either after hematopoietic stem cell allo-transplantation or in the anti-tumor effect to modulate Graft versus Host disease (GvHD) or to initiate anti-tumoral effects (Graft...
En savoir +Thierry Burnouf, PhD, is a Distinguished Professor and Vice-Dean at the College of Biomedical Engineering, Taipei Medical University, Taiwan. He established and leads a research lab focusing on platelets and extracellular vesicles for regenerative medicine, cell therapy, and drug delivery....
En savoir +After a master's degree in genetics and a Ph.D. on the role of Gas6 protein and precursor cells in steatohepatitis and hepatic fibrosis, Agnès advised companies in many sectors, particularly in industry, as a consultant in innovation financing. She was...
En savoir +MD degree, Freiburg University Supervisor of MD thesis: Radvan Urbanek, magna cum laude DEA immunology, Institut Pasteur, Paris Supervisor: Pierre Andre Cazenave PhD Immunology, Universite Paris VII Supervisor: Raif Geha, summa cum laude Residency in Pediatrics, Children’s Hospital Boston Fellowship...
En savoir +Jens Hasskarl is the chief medical officer of advesya, a French startup focused on developing lifesaving therapies. Prior to joining advesya, he was the chief medical officer of Tigen Pharma SA, a Swiss startup developing cellular therapies to fight solid...
En savoir +Dr Anaïck Moisan, PharmD and PhD, is the pharmacist responsible for the production and the release of ATMP used in regenerative medicine and clinical trials, in the Cell Therapy and Engineering Unit of EFS Rhône Alpes, based in St Ismier,...
En savoir +Dr GUILLONNEAU is Director of Research CNRS, head of team 2 at the Center of Research in Transplantation and Translational Immunology (CR2TI) in Nantes, France and director of the FOCIS Center of Excellence Nantes University. After a Postdoc in the...
En savoir +From the beginning of my career in 2001 at the “Etablissement Français du Sang” (EFS, BFC, Besançon), I became interested in translational research and more particularly to modulate the T cells lymphocyte response, such as T cells involved in host-graft-tumor...
En savoir +Prof de Pouvourville has graduated from Ecole Polytechnique in 1973 Formerly, he has led a career as a researcher in the field of health care economics and management, at Ecole polytechnique, at the French National School of Public Health and...
En savoir +Mathilde Girard is a stem cell specialist, specialized in bioproduction and automation for cell therapy applications. After a PhD in Human Genetics she specialized in pluripotent stem cells applications at the I-Stem institute in Evry. She notably led a research...
En savoir +